
Collaborative HCV Care with Pharmacists Could Address System-Level Treatment Barriers
New research is shedding light on the importance of collaborative care for facilitating community-based point-of-diagnosis hepatitis C virus (HCV) treatment initiation among high-risk, marginalized patient populations.1 In the No One Waits (NOW) trial, a …